Condition
High-Frequency Ventilation
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Unknown1
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04323397Not ApplicableCompletedPrimary
Nasal HFOV Versus Nasal SIPPV in Neonate Following Extubation: RCT Crossover Study
NCT05682937Not ApplicableTerminatedPrimary
HFOV With Intermittent Sigh Breaths in Neonate: Carbon Dioxide Level
NCT02712190Not ApplicableUnknown
Evaluation of Prolonged Apnea Supported by High Frequency Non-invasive Ventilation.
NCT02973373Not ApplicableCompleted
MRI of the Chest Under High Frequency Ventilation
Showing all 4 trials